EYPT FY 2017 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

EYPTEyePoint Pharmaceuticals, Inc.

$1B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+365.4% YoY

Gross Profit

$8M100.0% margin

Operating Income

-$19M-246.4% margin

Net Income

-$18M-245.2% margin

EPS (Diluted)

$-5.23

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$21M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$19M

Total Liabilities

$5M

Stockholders' Equity

$13M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$2M	+365.4%
Gross Profit	$8M	$805,000	+836.5%
Operating Income	-$19M	-$22M	+14.7%
Net Income	-$18M	-$22M	+14.2%